11th International Virtual Seminar on COVID-19 Part II
  • Follow

Accepted Abstracts

Identification, Isolation, Propagation and Inactivation of SARS-CoV2 Isolated from Egypt

Mohamed G Seadawy*, Ahmed F Gad, Mohamed Shamel, Bassem Elharty, Mostfa F Mohamed
Main Laboratories, Egypt

Citation: Seadawy MG, Gad AF, Shamel M, Elharty B, Mohamed MF (2020) Identification, Isolation, Propagation and Inactivation of SARS-CoV2 Isolated from Egypt. SciTech Central COVID-19

Received: December 01, 2020         Accepted: December 03, 2020         Published: December 03, 2020

Abstract

Severe acute respiratory syndrome coronavirus2 caused a pandemic disease called COVID-19.The COVID-19 appeared in China in 2019 Egypt become infected on Feb 2020 with SARS-CoV2. The pandemic virus consists of a positive single strand ssRNA. The spike protein of the virus is responsible for virus attachment with cell receptor angiotensin converting enzyme two (ACE2).The genome of SARS-CoV2 consists of two major portions.
The samples were taken from patients with COVID-19 symptoms at military hospital in Egypt and transported to the main chemical laboratories under all the biosafety measures according to WHO guidelines. All samples were tested with RT-PCR. Positive samples were cultured using VeroE6 cell lines. The propagated virus was isolated and inactivated .The isolated virus was sequenced using next generation sequencing and submitted into gene bank . This study can be referenced for researchers in Egypt who aimed to propagate and isolate SARS-CoV-2 to work in vaccine production, genomics, sequencing, proteomics, gene editing like CRISPR and anti-viral drug screening.
 
Key words: RT-PCR; SARS-CoV-2; COVID 19; VeroE6; Inactivated Vaccine.